...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >GENETIC IMPROVEMENT OF ANTIDIABETIC ALPHA-GLUCOSIDASE INHIBITOR PRODUCING STREPTOMYCES SP
【24h】

GENETIC IMPROVEMENT OF ANTIDIABETIC ALPHA-GLUCOSIDASE INHIBITOR PRODUCING STREPTOMYCES SP

机译:遗传改良抗生产α-葡糖苷酶抑制剂的链霉菌SP

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective : This study aims to control type 2 of diabetes mellitus by a hypoglycemic substance that extensively produced by Streptomyces bacteria. The antidiabetic action of this substance depends on prevention of starch hydrolysis and then the liberation of glucose monomers via an inhibition of α-glucosidase as one of starch hydrolyzing enzymes. Methods : The strains of marine actinomycetes were isolated on starch nitrate agar, and then qualitatively and quantitatively screened to prevent starch hydrolysis. The most potent strain was identified by classical and genetical methods. The genetic improvement of the most potent strain was carried out by using UV radiations at different exposure periods per second. The optimization of environmental conditions was studied to obtain the maximum activity of the α-glucosidase inhibitory protein, which purified and electrically separated to determine its molecular weight. Results : Among 55 marine actinomycetes, only 7 strains were found have antidiabetic activity. This activity was assayed spectrophotometrically at 400 nm, where p -nitrophenyl-α-d-glucopyranoside and acarbose were used as a substrate and a positive control respectively. The most potent strain which marked as AD-7 was identified as Streptomyces coelicolor , which exposed to the genetic improvement using UV radiations to obtain a highly activity of an inhibitory protein at 10 s of the exposure period. The activity and stability continued for 5 d at 37 °C. The maximum activity and stability of an improved inhibitory protein were obtained with optimization of environmental conditions included inoculum size (10 6 cfu/ml/300 μl), incubation period (14 d), agitation speed (160 rpm), incubation temperature (30 °C), and pH (8.5). An inhibitor was purified and separated at 34 KDa. Conclusion : Alpha-glucosidase inhibitory protein as a powerful hypoglycemic agent was extracted from the filtrate of S. coelicolor . The mutant strain of the latter had been produced most active and stable inhibitory protein, which prevents the starch hydrolysis via an inhibition of α-glucosidase enzyme for 5 d at 37 °C.
机译:目的:本研究旨在通过链霉菌细菌广泛产生的降血糖物质来控制2型糖尿病。该物质的抗糖尿病作用取决于防止淀粉水解,然后取决于作为淀粉水解酶之一的α-葡糖苷酶的抑制来释放葡萄糖单体。方法:在硝酸淀粉琼脂上分离海洋放线菌菌株,进行定性和定量筛选,以防止淀粉水解。通过经典和遗传方法鉴定出最有效的菌株。最强效菌株的遗传改良是通过使用每秒不同暴露时间的紫外线辐射进行的。研究了优化环境条件以获得最大活性的α-葡萄糖苷酶抑制蛋白,将其纯化并电分离以确定其分子量。结果:在55种海洋放线菌中,仅发现7株具有抗糖尿病活性。在400nm处用分光光度法测定该活性,其中将对-硝基苯基-α-d-吡喃葡萄糖苷和阿卡波糖分别用作底物和阳性对照。标记为AD-7的最有效菌株被鉴定为天蓝色链霉菌(Streptomyces coelicolor),该菌株在暴露于10 s的时间内使用紫外线辐射进行遗传改良,从而获得抑制蛋白的高活性。在37℃下活性和稳定性持续5天。通过优化环境条件(包括接种量(10 6 cfu / ml / 300μl),孵育时间(14 d),搅拌速度(160 rpm),孵育温度(30°C),可获得改善的抑制蛋白的最大活性和稳定性。 C)和pH(8.5)。纯化抑制剂,并在34 KDa下分离。结论:从天蓝色链霉菌的滤液中提取了α-葡萄糖苷酶抑制蛋白作为强效降糖药。后者的突变菌株已产生最具活性和稳定性的抑制蛋白,该蛋白通过在37°C下抑制α-葡萄糖苷酶5天来防止淀粉水解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号